Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070)

PURPOSE/BACKGROUND: The asenapine transdermal system (HP-3070) is the first antipsychotic patch approved in the United States for treatment of adults with schizophrenia. METHODS/PROCEDURES: Three phase 1, open-label, randomized studies characterized the pharmacokinetic (PK) profile of HP-3070 by ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Katsumi, Castelli, Mariacristina, Komaroff, Marina, Starling, Brittney, Terahara, Takaaki, Citrome, Leslie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083160/
https://www.ncbi.nlm.nih.gov/pubmed/33734167
http://dx.doi.org/10.1097/JCP.0000000000001383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8083160/
https://www.ncbi.nlm.nih.gov/pubmed/33734167
http://dx.doi.org/10.1097/JCP.0000000000001383

Ejemplares similares